Tern Plc Sells Part Holding in Device Authority

TERN

Tern Plc (LON:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things (“IoT”) technology businesses, has announced that it has sold part of its shareholding in Device Authority Limited for a total cash consideration of £233,000. As a consequence, Tern’s holding in Device Authority has reduced from 31.7% to 30.0% (before any dilution on the exercise of share options and the expected closing of Tranche Two of the Device Authority Fundraising announced on 27 December 2023).

This sale of equity in Device Authority equated to approximately 5.3% of Tern’s holding in Device Authority and has been undertaken at the same price as the Device Authority Fundraising announced by the Company on 27 December 2023 (the “Device Authority Fundraising Issue Price”). The buyer of Tern’s equity in Device Authority is an independent family office who are not currently a shareholder in Device Authority and not related to Tern. The proceeds of this disposal will be used to invest further in one or more of Tern’s portfolio companies and for general corporate purposes.

Tern’s reduced holding of 30.0% in Device Authority (before any dilution on exercise of share options and the expected closing of Tranche Two) has an unaudited book valuation of approximately US$5.4 million (approximately £4.2 million) at the valuation implied by the Device Authority Fundraising Issue Price.

The remaining Tranche Two of the Device Authority Fundraising of US$3.3 million, by Ten Eleven Ventures remains, as previously announced, to be completed on or prior to 30 September 2024. On completion of Tranche Two, by Ten Eleven Ventures, Tern will hold 25.3% of Device Authority’s equity (before any dilution on exercise of share options), which would be valued at approximately US$5.4 million (approximately £4.2 million) at the valuation implied by the Device Authority Fundraising Issue Price.

Unless otherwise stated, defined terms should be given the meaning given to them in the Company’s announcement made on 27 December 2023.

Commenting Ian Ritchie, Chairman of Tern, said: “Following the failure to pass the resolution required to issue new ordinary shares disapplying statutory pre-emption rights at the recent Annual General Meeting, the Tern board has been investigating ways to appropriately raise funds to protect Tern’s position in, and progress, Tern’s portfolio companies, whilst also providing Tern with funding as an AIM company. The sale of a modest proportion of our holding in Device Authority, at no discount to the value that Device Authority raised funds in December 2023, is, I believe, appropriate to meet the Company’s immediate requirements. We will continue to explore the best way to maximise shareholder value and I look forward to providing updates on our portfolio companies in due course.”

Further information on Device Authority

Device Authority is a global leader in Identity and Access Management (“IAM”) for the IoT; focused on the automotive, medical device (“IoMT”) and industrial (“IIoT”) sectors. Device Authority’s KeyScaler™ platform provides zero touch provisioning and complete automated lifecycle management for securing IoT devices and data at scale, with frictionless deployment across device provisioning, authentication, credential management, policy based end-to-end data security/encryption and secure OTA (over the air) and HSM (hardware security module) updates.

Based on Device Authority’s latest statutory accounts for the year ended 31 December 2023, as at that date it had net assets of £11,024,568 and incurred a profit for the year of £4,303,751. Given the statutory nature of these figures Tern does not consider this profit to be representative of the current business and trading performance of Device Authority.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines examines factors influencing prescribing decisions

Talking Medicines explains how healthcare professional conversations, clinical considerations and treatment perceptions can provide pharmaceutical companies with deeper insight into prescribing intent beyond traditional campaign metrics.

What HCPs say could reveal prescribing intent

Talking Medicines is using AI to analyse HCP conversations and identify the clinical and practical factors that may influence prescribing intent.

AI control of machines raises new security questions

AI is gaining the ability to control physical equipment, but establishing that machines are genuine, authorised and secure will be an important part of making this technology safe to deploy.

CAR-T therapy brings new approach to multiple myeloma treatment

CAR-T therapy is being used in multiple myeloma and is being studied earlier in the treatment pathway, with research focused on improving durability, safety and access.

Tern cuts H1 loss by 60% as portfolio growth and funding strengthen

Tern reduced its first-half loss by 60%, with net asset value improving and further fundraising strengthening the balance sheet. Additional funding has supported Talking Medicines and Device Authority, while continued progress across the portfolio provides further scope for value creation.

AI control of machines creates a new market for device trust

AI is beginning to control physical machines, increasing demand for technology that can verify device identity before those machines are allowed to act.

Search